Medpace Holdings, Inc

Add to watchlist
€139.0
Last updated:07/27/2021
01P: F
Medpace Holdings, Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also p… Show more

P/E ratio
38.75x
vs. 41.49x forward

Price is 38.75x times more than EPS €3.59 which eaquals €139.0

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Dr. August James Troendle
Market capitalization
Mid (5.06B)